Could a herpes drug slow Alzheimer's? new study tests the idea
NCT ID NCT03282916
First seen Nov 01, 2025 · Last updated May 23, 2026 · Updated 22 times
Summary
This study tested whether the antiviral drug valacyclovir (Valtrex) can slow memory and thinking decline in people with mild Alzheimer's disease who also carry the herpes simplex virus. About 120 participants received either the drug or a placebo for 18 months. The goal was to see if treating a common virus could help control Alzheimer's symptoms.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ALZHEIMER DISEASE are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Banner Alzheimer's Institute (BAI)
Phoenix, Arizona, 85006, United States
-
New York State Psychiatric Institute
New York, New York, 10032, United States
-
New York University School of Medicine
New York, New York, 10016, United States
Conditions
Explore the condition pages connected to this study.